Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey K Tong

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Chemistry & Biology|June 25, 2002
Dissecting histone deacetylase functionJeffrey K Tong
Journal of Medicinal Chemistry|July 21, 2006
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90Jie Ge, Emmanuel Normant, James R Porter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90Jens R Sydor, Emmanuel Normant, Christine S Pien, et al.
Journal of Medicinal Chemistry|October 10, 2008
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Chemistry & Biology|June 25, 2002
Dissecting histone deacetylase functionJeffrey K Tong
Journal of Medicinal Chemistry|July 21, 2006
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90Jie Ge, Emmanuel Normant, James R Porter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90Jens R Sydor, Emmanuel Normant, Christine S Pien, et al.
Journal of Medicinal Chemistry|October 10, 2008
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.
Pageof 1